[Heart Rate and Cardioprotection: New Data and Perspectives].
The article presents the results of new experimental and clinical studies of selective inhibitor of If-channel, ivabradine confirming the feasibility of its use in coronary heart disease and chronic heart failure. We discuss some of the pleiotropic effects of ivabradine. Ivabradine may be useful in therapeutic areas outside those where it has previously demonstrated clinical efficacy.